Methods of delivering a prosthetic aortic heart valve are disclosed. The disclosed methods include loading a prosthetic aortic valve in a collapsed configuration into a delivery sheath so that a selected point on the prosthetic valve is rotationally aligned relative to a long axis of the delivery sheath with a selected radiopaque marker on the delivery sheath, while under fluoroscopic imaging, rotating the delivery sheath about its long axis to align a selected radiopaque marker on the delivery sheath with the selected point on the native aortic valve in a fluoroscopic imaging plane, thereby establishing a desired orientation of the prosthetic aortic valve with respect to the native aortic valve in which the prosthetic valve commissures are rotationally aligned with commissures of the native aortic valve, further advancing the delivery sheath along its long axis until the prosthetic aortic valve is disposed inside the native aortic valve, and deploying the prosthetic aortic valve into an implanted state inside the native aortic valve with the prosthetic aortic valve aligned in the desired orientation with respect to the native aortic valve.

A method for fabricating a cornea includes affixing a frame to at least one cell culture insert comprising a generally cylindrical structure having a proximal end and a distal end, a base disposed at the proximal end, and a porous membrane disposed between the proximal end and the distal end; affixing a dome-shaped member to the porous membrane within the frame, the dome-shaped member comprising a crown, a dome base, and a surface connecting the crown and the dome base; depositing a material comprising a matrix-forming compound on the frame such that the crown and at least a portion of the surface of the dome-shaped member is coated with the material comprising the matrix-forming compound; and removing the dome-shaped member to produce a fabricated cornea attached to the frame. A system for fabricating a cornea and a cornea scaffold are also described herein.

The three-dimensional lattice structures disclosed herein have applications including use in medical implants, Some examples of the lattice structure are structural in that they can be used to provide structural support or mechanical spacing In some examples, the lattice can be configured as a scaffold to support bone or tissue growth Some examples can use a repeating modified rhombic dodecahedron or radial dodeca-rhombus unit cell. The lattice structures are also capable of providing a lattice structure with anisotropic properties to better suit the lattice for its intended purpose.

Reversibly deformable corneal implants for replacing excised corneal tissue, the implants including an optical portion and an anchoring portion having different mechanical properties from each other.

A prosthetic capsular device configured to be inserted in an eye after removal of a lens, in some embodiments, can comprise a housing structure comprising capable of containing an intraocular device. The housing structure can comprise an anterior portion comprising an anterior opening, a posterior portion comprising a posterior opening, and a continuous lateral portion between the anterior portion and the posterior portion.

A prosthetic valve assembly includes a prosthetic valve and an anchoring frame. The prosthetic valve includes a valve frame and a valve structure. The valve frame includes a plurality of struts and is expandable from a compressed configuration to an expanded configuration. The valvular structure includes leaflets. The valvular structure is disposed radially within and is coupled to the valve frame. The valvular structure is configured to allow blood flow through the prosthetic valve assembly in a first direction and to restrict blood flow through the prosthetic valve assembly in a second direction. The anchoring frame includes a plurality of struts. The anchoring frame is disposed radially outwardly from and is coupled to the valve frame. The struts of the anchoring frame comprise one or more tissue-engaging elements configured for contacting native tissue to help secure the prosthetic valve assembly at an implantation location.

Apparatuses, systems and methods for providing improved ophthalmic lenses, particularly intraocular lenses (IOLs), include features for reducing adverse optical effects from diffractive profiles of such a lens. Exemplary ophthalmic lenses can include an optic including a diffractive profile including a transition zone having an elevated surface roughness.

A partial endoprosthesis device preserves the motion of a vertebral joint for implant into a spinal segment and includes an articular portion having a thickness that increases in the direction of introduction between the articular facets. The articular portion is elongated along a longitudinal axis with a opposite first and second faces. The first face has a central protrusion that is configured so that, by implanting the device with the articular portion inserted between an upper articular facet of a lower vertebra and a corresponding lower articular facet of upper vertebra adjacent to the lower vertebra, and with the first face in contact with either the upper or lower articular facet, and with the second face in contact with the other articular facet, the articular portion, with the first face, pushes against the first articular facet and finally becomes integral by osteointegration with the lower articular facet.

The present disclosure relates to an intravascular stent, preparation method and use thereof, and the intravascular stent comprises a positioning segment and a supporting segment, the positioning segment comprising a plurality of first repeating elements, the supporting segment comprising at least two supporting units and at least one connecting unit, the supporting unit comprising a plurality of second repeating elements, the number of the first repeating elements differing from the number of the second repeating elements, a plane formed by front ends of the plurality of first repeating elements being vertical to or intersecting with the axis of the intravascular stent. The intravascular stent of the present disclosure is particularly suitable for iliac vein, with good supporting effect for iliac vein and less damage to venous wall, and can effectively avoid forming in-stent secondary thrombosis after intravascular stent implantation. Moreover, the intravascular stent of the present disclosure can be well positioned in the iliac vein to improve the accuracy of the release, and it is simple for operation. The vascular stent of the present disclosure has the advantages of simple structure, convenient production and low cost, and thereby has important practical significance and good prospect in clinical application.

The present disclosure relates to tissue matrix products. The products can includes tissue matrices that have holes or perforations located at certain positions to improve certain in vivo functions without substantial loss of strength or other important properties.